Autologous dendritic cell vaccine for estrogen receptor (ER)/progestin receptor (PR) double-negative breast cancer

2012 ◽  
Vol 61 (9) ◽  
pp. 1415-1424 ◽  
Author(s):  
Chun-Jian Qi ◽  
Yong-Ling Ning ◽  
Ye-Shan Han ◽  
Hai-Yan Min ◽  
Heng Ye ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Estrogen Receptor ◽  
Dendritic Cell ◽  
Dendritic Cell Vaccine ◽  
Cell Vaccine ◽  
Double Negative ◽  
Autologous Dendritic Cell ◽  
Progestin Receptor

scholarly journals An autologous dendritic cell vaccine polarizes a Th-1 response which is tumoricidal to patient-derived breast cancer cells

2018 ◽  
Vol 68 (1) ◽  
pp. 71-83 ◽  
Author(s):  
Michele Tomasicchio ◽  
Lynn Semple ◽  
Aliasgar Esmail ◽  
Richard Meldau ◽  
Philippa Randall ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Dendritic Cell ◽  
Cancer Cells ◽  
Breast Cancer Cells ◽  
Dendritic Cell Vaccine ◽  
Cell Vaccine ◽  
Autologous Dendritic Cell ◽  
Th 1

Portulaca oleracea L. polysaccharides enhance the immune efficacy of dendritic cell vaccine for breast cancer

2021 ◽  
Author(s):  
Guiyan Jia ◽  
Xingyue Shao ◽  
Rui Zhao ◽  
Tao Zhang ◽  
Xiechen Zhou ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Dendritic Cell ◽  
Signaling Pathway ◽  
Mechanism Of Action ◽  
Dendritic Cell Vaccine ◽  
Portulaca Oleracea ◽  
Cell Vaccine ◽  
Dc Vaccine ◽  
Immune Efficacy ◽  
Dc Maturation

POL-P3b, as a promising dietary adjuvant for the DC vaccine of breast cancer, could induce DC maturation and the mechanism of action involved in the TLR4/MyD88/NF-κB signaling pathway.

Sign in / Sign up

Export Citation Format

Share Document